Advertisement

Picture EBD Group Asia Bio Partnering Forum 2025 Singapore to 18 Jul 650x100px
Organisation › Details

Oxford Sciences Innovation plc (OSI)

Oxford Sciences Innovation (OSI) is a leading science and technology business. OSI ensures Oxford’s world-leading science moves out of the laboratory and onto the global stage. In partnership with the University of Oxford, OSI creates fundamental technology companies, built on science. We match scientists with experienced entrepreneurs and patient capital to turn idea to impact, discovery to company. OSI invests in Life Sciences, Deep Tech, Healthtech, AI and Software to create companies taking on challenges like diagnosis and treatment of disease and cancer, hyper resolution microscopy, renewable energy, drones, nuclear fusion and quantum computing. Founded in 2015, we’ve raised over $800M of evergreen capital, building on Oxford’s renowned research legacy, to create a leading science and technology ecosystem and home for entrepreneurs. OSI backs companies from their inception and invest for the long-term, helping them to build their businesses by finding senior management talent, entrepreneurs, expert advisors and global investors to realise their vision. OSI reinvests any returns back into the Oxford ecosystem and the next generation of scientists and technologies to create even more companies capable of tackling more of the world’s most important problems. *

 

Period Start 2015-05-01 established
Period End 2022-03-31 renamed before
  Group Oxford Science Enterprises (Group)
  Today Oxford Science Enterprises plc
  Successor Oxford Science Enterprises plc
Products Industry IP services
  Industry 2 venture capital
     
Region Region Oxford, Oxfordshire
  Country United Kingdom (GB)
  Street 46 Woodstock Road
  City OX2 6HT Oxford, Oxfordshire
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
  Currency USD
  Annual sales 800,000,000 (capital, evergreen (2020) 2020-12-09)
     
    * Document for »About Section«: PepGen Ltd.. (12/9/20). "Press Release: PepGen Raises $45M Series A". Boston, MA & Oxford.
     
   
Record changed: 2025-03-16

Advertisement

Picture Consultech GmbH New EU Grants v2 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px




» top